Article Details

Summit Therapeutics (SMMT) Is Up on Positive Phase III Data for Ivonescimab in EGFR ...

Retrieved on: 2025-09-14 16:53:27

Tags for this article:

Click the tags to see associated articles and topics

Summit Therapeutics (SMMT) Is Up on Positive Phase III Data for Ivonescimab in EGFR .... View article details on hiswai:

Excerpt

... monoclonal antibodies have previously not succeeded in Phase III global clinical trials. We'll explore how the clinical differentiation of ...

Article found on: simplywall.st

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo